Form 8-K bioAffinity Technologies For: Jun 16

Thu, 18 Jun 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260618/26667177.html

Form 8-K bioAffinity Technologies For: Jun 16

Thu, 18 Jun 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260618/26667177.html

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

JERSEY CITY, N.J., June 18, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, closed its previously announced public offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company.

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Thu, 18 Jun 2026 14:54:00 -0400

bioAffinity Technologies closes $3.2M public offering

Thu, 18 Jun 2026 13:17:37 -0400

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) announced the closing of a public offering that raised $3.2 million in gross proceeds, before deducting agent fees and other expenses, according to a company press release.

The offering consisted of 4,000,000 shares of common stock at a purchase price of $0.80 per share, with a par value of $0.007 per share. Pre-funded warrants were also available in lieu of shares at a price of $0.793 per warrant, each exercisable for one share of common stock. The warrants are immediately exercisable and expire upon full exercise.

The closing was expected to occur on or about June

bioAffinity Technologies closes $3.2M public offering

Thu, 18 Jun 2026 13:17:37 -0400

The closing was expected to occur on or about June

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW),a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced the closing of its previously announced public offering of securities as described below for aggregate gross proceeds to the Company of $3.2 million, before deducting agent fees and other estimated expenses payable by the company.

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Thu, 18 Jun 2026 13:16:00 -0400

The offering consisted of 4,000,000 shares of its common stock, par value $0.007 per share (or pre-funded warrants in lieu thereof) at a purchase price

Form 424B4 bioAffinity Technologies

Thu, 18 Jun 2026 09:25:00 -0400

si-local-file:///var/storage/secattach/20260618/26663886.html

StreetInsider.com News Articles

Form 8-K bioAffinity Technologies For: Jun 16

Form 8-K bioAffinity Technologies For: Jun 16

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

bioAffinity Technologies closes $3.2M public offering

bioAffinity Technologies closes $3.2M public offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Form 424B4 bioAffinity Technologies